Clinical Trial Update: A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating VM902A for analgesia in knee osteoarthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• VM902A

Snippet

Sponsor: Purdue Pharma LP | Conditions: Osteoarthritis Pain of the Knee | Phase 2 | Status: TERMINATED